Skip to main content
. 2016 Jun 23;11(6):e0157801. doi: 10.1371/journal.pone.0157801

Table 3. ROC analysis to predict the diagnostic impact of the miRNA and mRNA target expression.

Marker AUC (95% CI)
between N and ccRCC between ccRCC-M0 and ccRCC-M1
HS6ST2 0.974 (0.941–1.000)**** 0.697 (0.492–0.902)ns
LOX 0.849 (0.725–0.973)**** 0.811 (0.644–0.979)**
miR-141 0.912 (0.815–1.000)**** 0.539 (0.315–0.763)ns
miR-145 0.711 (0.565–0.857)** 0.694 (0.492–0.897)ns

AUC = area under the curve; N = non-malignant renal tissue from ccRCC patients; ccRCC = malignant renal tissue from ccRCC patients; ccRCC-M0 = malignant renal tissue from ccRCC patients without metastasis; ccRCC-M1 = malignant renal tissue from ccRCC patients with metastasis

** p < 0.01

**** p < 0.0001; ns = not significant